Anthropic expands Claude's life sciences ecosystem for drug discovery

Anthropic is connecting Claude to scientific platforms and data sources for drug discovery, clinical development and regulatory documentation. Partners and customers include Sanofi, Novo Nordisk, Genmab, Schrödinger, the Broad Institute and Stanford, with integrations such as Benchling, PubMed, ChEMBL and Open Targets.

• Partners and customers include Sanofi, Novo Nordisk, Genmab and Schrödinger
• Integrations cover Benchling, PubMed, BioRender, Wiley Scholar Gateway and ChEMBL
• Claude targets literature review, clinical-trial design and regulatory work
• Anthropic has not confirmed an in-house drug discovery program